Applied Therapeutics
Manufacturing · Michigan, United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
19 Clifford St, Detroit, Michigan, 48226...Phone Number
(800) 903-1793Website
www.appliedtherapeutics.comRevenue
<$5 MillionStock Symbol
APLTIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
4
2
1
1
1
1
About Applied Therapeutics
Applied Therapeutics is a clinical-stage biopharmaceutical company developing a pipeline of novel drug candidates against validated molecular targets in indications of high unmet medical need. Applied Therapeutics' portfolio includes three Phase 3 programs for diseases with high unmet medical need and no approved treatment options. The Company's lead drug candidate, AT-007, is a novel central nervous system penetrant Aldose Reductase Inhibitor (ARI) for the treatment of CNS rare metabolic diseases, including Galactosemia and SORD Deficiency. The Company is also developing AT-001, a novel potent ARI, for the treatment of Diabetic Cardiomyopathy, or DbCM, a fatal fibrosis of the heart.Explore more
Applied Therapeutics Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Applied Therapeutics your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Product Launch: Get notified when Applied Therapeutics launches new products
Applied Therapeutics, which may be a good buyer, showed buying intent in Masked Content Topic
Funding: Get notified immidiatlly once Applied Therapeutics has new funding data
Check if Applied Therapeutics has recently received funding, and reach out quickly before it becomes old news!
Earning: See what the market has to say on Applied Therapeutics recently announced quarterly report
Congratulate Masked Content for being promoted to Masked Content at Applied Therapeutics
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Click to see if Applied Therapeutics had a recent Job posting/layoffs
Check out if Applied Therapeutics is spiking on competitors!
Website visits: Recent activity has been detected on your website
Recommended Actions
Reach out to Masked Content who joined Applied Therapeutics as Masked Content
Find 3 more new buyers
Compare Similar Companies to Applied Therapeutics
Compare insights from companies similar to Applied Therapeutics, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Applied Therapeutics
<$5M
11-50
Public
$99M
2016
DC
Dottie CaplanExecutive VP, Patient Advocacy & Government Affairs
Company Profile Activity
Activity Insights
Applied Therapeutics is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Applied Therapeutics is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Applied Therapeutics.
Applied Therapeutics financials insights
Gather financial insights about Applied Therapeutics, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2021
Share Placement
$69M
2023
Share Placement
$30M
Applied Therapeutics Tech Stack
A closer look at the technologies used by Applied Therapeutics
See more technologies
Most Recent Scoops
Left Company
Executive Move
Executive Moves, Left Company
Project
Spending/Investment, Lawsuits, Legal Affairs, Settlement
Mergers & Acquisitions (M&A)
Mergers & Acquisitions, Acquisitions, Mergers
Layoffs
Pain Point
Pain Point, Layoffs
Person-Based
Applied Therapeutics News & Media
Applied Therapeutics $15M Securities Class Action Settlement - Claim Depot
Individuals who purchased Applied Therapeutics stock between Jan. 3 and Dec. 2, 2024, may be eligible to claim a cash payment from a class action settlement.Cycle Pharmaceuticals to Acquire Applied Therapeutics
Applied Therapeutic’s lead drug candidate, govorestat, is a novel central nervous system penetrant Aldose Reductase Inhibitor for the treatment of CNS rare metabolic diseases Applied Therapeutic’s lead drug candidate, govorestat, is a novel central nervous system penetrant Aldose Reductase Inhibitor for the treatment of CNS rare metabolic diseasesApplied Therapeutics To Lay Off Nearly Half Its Staff, Board Explores M&A Options
The board is considering mergers, acquisitions, partnerships, joint ventures, licensing arrangements or other strategic transactions, the company said.Applied Therapeutics Announces Corporate Updates
NEW YORK, Nov. 20, 2025 (GLOBE NEWSWIRE) -- Applied Therapeutics, Inc. (Nasdaq: APLT) (the “Company”), a clinical-stage biopharmaceutical company dedicated to creating transformative treatments for rare diseases, today announced that Applied Therapeutics’ Board of Directors (the “Board”) has initiated a process to explore strategic alternatives for the Company.
Read more news
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Applied Therapeutics
Sign Up For FreeTo access detailed company insights
Applied Therapeutics is a clinical-stage biopharmaceutical company developing a pipeline of novel drug candidates against validated molecular targets in indications of high unmet medical need. Applied Therapeutics' portfolio includes three Phase 3 programs for diseases with high unmet medical need and no approved treatment options. The Company's le... Read More
